Skip to content

Perioperative Immunonutrition Under Enhanced Recovery After Surgery

Perioperative Immunonutrition Among Gynecological Cancer Patients Under Enhanced Recovery After Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06039306
Acronym
PING-ERAS
Enrollment
106
Registered
2023-09-15
Start date
2024-09-01
Completion date
2025-10-30
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective Surgery, Gynecological Cancer

Keywords

gynecological cancer, elective surgery

Brief summary

The goal of this clinical trial is to compare the effect of perioperative immunonutrition supplement in gynecologic cancer patients. The main questions it aims to answer are: * is there any difference in the nutritional outcomes and functional outcomes between intervention and conventional groups? * is there any difference in the post-surgical outcomes between intervention and conventional groups? Participants (intervention) will be provided the immunonutrition supplement before and after operation. Researchers will compare intervention group with conventional group to see if there is any difference in postoperative outcomes.

Detailed description

The clinical trial aims to determine the effectiveness of perioperative IMN intervention on postoperative outcomes among GC patients under Enhanced Recovery after Surgery (ERAS) setting. Patients will prescribed with immunonutrition supplement before and after surgery.

Interventions

DIETARY_SUPPLEMENTImmunonutrition oral nutrition supplementation

Participant will prescribed with 2 servings of immunonutrition supplement 5 days before surgery and 7 days after surgery

Sponsors

Universiti Putra Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

After consented, participants will be randomized into two groups: the intervention group and conventional group during consultation in multidisciplinary clinic.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Those who diagnosed with GC 2. Candidates for elective operation treatments

Exclusion criteria

1. Those are involved gastrointestinal tract (complication) 2. Those are diagnosed with GC (metastasis) 3. Allergy to milk/soy/whey protein 4. Participate in other intervention study

Design outcomes

Primary

MeasureTime frameDescription
body composition1 monthbody composition analyzer; weight in kg; fat free mass in kg; fat mass in kg; muscle mass in kg; height in meter
C-reactive protein1 monthConcentration of C-reactive protein
postoperative outcomes1 monthslength of hospitalization
daily energy and protein intake1 month24-hours diet recall
immunoglobulin level1 monthConcentration of immunoglobulin G; Concentration of immunoglobulin A; Concentration of immunoglobulin M

Secondary

MeasureTime frameDescription
stress level1 monthquestionnaire 10-item perceived stress scale (PSS-10) form
Functional status1 monthhandgrip strength in kg via Jammar dynamometer

Countries

Malaysia

Contacts

Primary ContactChiouYi Ho
agneshcy0326@gmail.com0388925555
Backup ContactZulfitri 'Azuan Mat Daud
zulfitri@upm.edu.my

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026